The potential of metabolomic approaches for investigating mode(s) of action of xenobiotics: Case study with carbon tetrachloride

被引:17
作者
Vulimiri, Suryanarayana V. [1 ]
Berger, Alvin [2 ]
Sonawane, Babasaheb [1 ]
机构
[1] US EPA, Natl Ctr Environm Assessment, Off Res & Dev, Washington, DC 20460 USA
[2] Univ Minnesota, Dept Food Sci & Nutr, St Paul, MN 55108 USA
关键词
Metabolomics; Mode of action; Xenobiotics; Carbon tetrachloride; INDUCED LIPID-PEROXIDATION; GENE-EXPRESSION PROFILES; OXIDATIVE STRESS; RAT-LIVER; GLUTATHIONE DEPLETION; CAPILLARY-ELECTROPHORESIS; GAS-CHROMATOGRAPHY; DRUG TOXICITY; METABONOMICS; URINE;
D O I
10.1016/j.mrgentox.2010.02.013
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Both experimental animals and humans exhibit complex cellular responses upon exposure to xenobiotics and may undergo similar types of metabolic changes leading to adverse outcomes. Exposure to xenobiotics results in perturbation of many cellular events (e.g. oxidative stress, lipid peroxidation, inflammation, genotoxicity, cytotoxicity, etc.), and during this process biochemicals (endogenous metabolites) of a given metabolic pathway are increased, decreased or unaffected. Metabolomics is an emerging medium to high-throughput technology that can automatically identify, quantify and characterize hundreds to thousands of low molecular weight biochemicals simultaneously, using targeted or global analytical approaches, yielding a metabolic fingerprint and understanding of biochemical pathway perturbations. Herein, we illustrate how metabolomics can be utilized to explore the mechanisms of action of xenobiotics which affect different 'key events' contributing to different mode(s) of action. The extensively studied hepatotoxicant carbon tetrachloride (CCl(4)) is specifically described. Published by Elsevier B.V.
引用
收藏
页码:147 / 153
页数:7
相关论文
共 96 条
[1]   Screening for the Drug-Phospholipid Interaction: Correlation to Phospholipidosis [J].
Alakoskela, Juha-Matti ;
Vitovic, Pavol ;
Kinnunen, Paavo K. J. .
CHEMMEDCHEM, 2009, 4 (08) :1224-1251
[2]   Metabolomics of the interaction between PPAR-α and age in the PPAR-α-null mouse [J].
Atherton, Helen J. ;
Gulston, Melanie K. ;
Bailey, Nigel J. ;
Cheng, Kian-Kai ;
Zhang, Wen ;
Clarke, Kieran ;
Griffin, Julian L. .
MOLECULAR SYSTEMS BIOLOGY, 2009, 5
[3]   Highly-parallel metabolomics approaches using LC-MS2 for pharmaceutical and environmental analysis [J].
Bajad, Sunil ;
Shulaev, Vladimir .
TRAC-TRENDS IN ANALYTICAL CHEMISTRY, 2007, 26 (06) :625-636
[4]   Etheno-adduct-forming chemicals: from mutagenicity testing to tumor mutation spectra [J].
Barbin, A .
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2000, 462 (2-3) :55-69
[5]   Acceleration of Purine Degradation by Periodontal Diseases [J].
Barnes, V. M. ;
Teles, R. ;
Trivedi, H. M. ;
Devizio, W. ;
Xu, T. ;
Mitchell, M. W. ;
Milburn, M. V. ;
Guo, L. .
JOURNAL OF DENTAL RESEARCH, 2009, 88 (09) :851-855
[6]   Carbon tetrachloride-induced lipid peroxidation: eicosanoid formation and their regulation by antioxidant nutrients [J].
Basu, S .
TOXICOLOGY, 2003, 189 (1-2) :113-127
[7]   Chloroform, carbon tetrachloride and glutathione depletion induce secondary genotoxicity in liver cells via oxidative stress [J].
Beddowes, EJ ;
Faux, SP ;
Chipman, JK .
TOXICOLOGY, 2003, 187 (2-3) :101-115
[8]  
BEGER RD, 2009, TOXICOL APPL PHARM
[9]   Metabolic Biomarker and Kinase Drug Target Discovery in Cancer Using Stable Isotope-Based Dynamic Metabolic Profiling (SIDMAP) [J].
Boros, Laszlo G. ;
Brackett, Daniel J. ;
Harrigan, George G. .
CURRENT CANCER DRUG TARGETS, 2003, 3 (06) :445-453
[10]   Discovery of Metabolomics Biomarkers for Early Detection of Nephrotoxicity [J].
Boudonck, Kurt J. ;
Mitchell, Matthew W. ;
Nemet, Laszlo ;
Keresztes, Lilla ;
Nyska, Abraham ;
Shinar, Doron ;
Rosenstock, Moti .
TOXICOLOGIC PATHOLOGY, 2009, 37 (03) :280-292